<DOC>
	<DOCNO>NCT01480817</DOCNO>
	<brief_summary>The investigator go compare therapeutic effect sorafenib transarterial chemoembolization advance hepatocellular carcinoma major branch portal vein invasion .</brief_summary>
	<brief_title>Sorafenib VS TACE HCC Patients With Portal Vein Invasion</brief_title>
	<detailed_description>TACE establish therapy patient unresectable hepatocellular carcinoma ( HCC ) show significantly improve survival patient compare treatment . Moreover , TACE perform safely may improve overall survival patient HCC major branch portal vein invasion . Sorafenib , already approve HCC , could lead significantly improvement tumor control survival patient advanced stage HCC . So far head head comparison report efficacy Sorafenib TACE . Here investigator evaluate efficacy sorafenib TACE advance HCC major branch portal vein invasion .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Sorafenib</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<criteria>1 . 80 &gt; Age &gt; = 18 year . 2 . ChildPugh class A ( class B could include Childs score 7 ) . 3 . Hepatocellular carcinoma major branch portal vein invasion dynamic CT MRI newly diagnose treatmentnaive patient , also HCC patient previously treat therapy case development major branch portal vein invasion 4 . Adequate bone marrow , liver renal function assess follow laboratory requirement : White blood cell count ( WBC ) &gt; = 2,000 /μl , Absolute neutrophil count ( ANC ) &gt; 1,200/μl Hemoglobin &gt; = 8.0 g/dl Platelet count &gt; 50,000/μl Serum creatinine &lt; 1.7 mg/dl Total bilirubin = &lt; 3.0 mg/dl Prothrombin Time ( PT ) international normalize ratio ( INR ) = &lt; 2.3 Prothrombin Time ( PT ) sec = &lt; 6 sec 5 . Eastern Cooperative Oncology Group ( ECOG ) Performance Status 02 . 1 . ChildPugh score &gt; = 8 . 2 . Age &lt; 18 &gt; = 80 year . 3 . ECOG Performance Status &gt; = 3 . 4 . Recipient live donor decease donor liver transplantation 5 . Patients unable understand content inform consent refuse sign inform consent . 6 . Patients evidence uncontrolled severe medical condition require treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>